Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,859.00    42.00 (2.31%)
Bid:
1,856.00
Ask:
1,858.00
Spread: 2.00 (0.108%)
Market Cap: £2.08b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Convertible bond offering

17 May 2011 15:45

RNS Number : 7733G
Derwent London PLC
17 May 2011
Β 

ο»Ώ

17 May 2011

Β 

NOT FOR DISTRIBUTION IN OR TO THE U.S., CANADA, AUSTRALIA OR JAPAN, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW

Β 

Derwent London plc Convertible Bond Offering

Β 

Derwent London plc (the "Group", the "Company" or "Derwent London") announces the final terms of its offering of Β£175 million of Convertible Bonds due 2016 (the "Bonds"), announced earlier today.

Β 

The Bonds will have a coupon of 2.75% per annum payable semi-annually in arrear and will be convertible into fully paid Ordinary Shares of the Company ("the Shares"). The initial conversion price has been set at Β£22.22, a premium of 30% above the volume weighted average price of the Shares from launch to pricing less the Β£0.2025 to be paid to shareholders on the share register on 20 May 2011.

Β 

Settlement is expected to take place on or about 2 June 2011 (the "Settlement Date").

Β 

John Burns, Chief Executive Officer of Derwent London said:

Β 

"We are very pleased with the result of this bond offer and the confidence that the market has shown in the future prospects of the Group. The bonds have been priced at the top end of the premium range and the transaction was substantially oversubscribed at that level."

Β 

J.P. Morgan Cazenove and RBS Hoare Govett Limited are acting as Joint Global Coordinators and Joint Bookrunners and HSBC Bank plc and UBS Limited are acting as Joint Bookrunners for the offering.

Β 

For further information, please contact:

Derwent London John Burns, Chief Executive Officer

Tel: +44 (0)20 7659 3000 Damian Wisniewski, Finance Director

Β 

About Derwent London plc

Derwent London plc is the largest central London focused REIT with an investment portfolio of Β£2.4bn as at 31 December 2010. The Group is one of London's most innovative office specialist property regenerators and investors and is well known for its established design-led philosophy and creative management approach to development.

Β 

Derwent London's core strategy is to acquire and own a portfolio of central London property that has reversionary rents and significant opportunities to enhance and extract value through refurbishment, regeneration and redevelopment. The Group owns and manages an investment portfolio of 5.4 million sqft (500,000m2), as at 31 December 2010, of which 95% is located in central London, with a specific focus on the West End and the areas bordering the City of London. Landmark schemes by Derwent London include Angel Building EC1, Arup Phases II & III W1, Qube W1, Horseferry House SW1, Johnson Building EC1, Davidson Building WC2 and Tea Building E1.

Β 

Derwent London came first in the property sector in the 2010 awards for 'Britain's Most Admired Companies'.

Β 

DISCLAIMER

This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities in the United States or in any other jurisdiction. This announcement is not for distribution, directly or indirectly in or into the United States (as defined in Regulation S under the US Securities Act of 1933, as amended (the "Securities Act")). The securities referred to herein have not been and will not be registered under the Securities Act and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

Β 

This communication is directed only at persons who (i) are outside the United Kingdom or (ii) have professional experience in matters relating to investments falling within Article 19(5) of The Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) are persons falling within Article 49 2(a) to (d) of the Order (all such persons together being referred to as "relevant persons"). This communication must not be read, acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this communication relates is available only to relevant persons and will be engaged in only with relevant persons.

Β 

The Joint Bookrunners are acting on behalf of the issuer and the Company and no one else in connection with the Bonds and will not be responsible to any other person for providing the protections afforded to clients of the Joint Bookrunners or for providing advice in relation to the Bonds.

No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by the Joint Bookrunners or by any of their respective officers, employees or agents as to or in relation to the accuracy or completeness of this any written or oral information made available to any interested party or its advisers and any liability therefor is hereby expressly disclaimed.

Stabilisation/FSA.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
CONSFEFLWFFSELI
Date   Source Headline
28th Feb 20237:01 amRNSDerwent London Leasing Update
28th Feb 20237:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2022
31st Jan 202311:30 amRNSTotal Voting Rights
24th Jan 202310:30 amRNSDirector Declaration
20th Jan 20232:50 pmRNSHolding(s) in Company
19th Jan 20232:30 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSSale of 19 Charterhouse Street EC1
30th Dec 20221:15 pmRNSTotal Voting Rights
6th Dec 20224:00 pmRNSHolding(s) in Company
30th Nov 20224:30 pmRNSTotal Voting Rights
16th Nov 202212:15 pmRNSHolding(s) in Company
3rd Nov 20227:00 amRNSThird Quarter Business Update
31st Oct 20224:45 pmRNSTotal Voting Rights
19th Oct 20223:31 pmRNSDirector/PDMR Shareholding
13th Oct 20225:20 pmRNSHolding(s) in Company
11th Oct 20222:15 pmRNSDirector/PDMR Shareholding
30th Sep 20224:45 pmRNSTotal Voting Rights
21st Sep 20225:00 pmRNSDirector/PDMR Shareholding
20th Sep 20224:30 pmRNSBlock listing Interim Review
31st Aug 20224:45 pmRNSTotal Voting Rights
25th Aug 20229:15 amRNSAdditional Listing
17th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 202211:00 amRNSDirector/PDMR Shareholding
12th Aug 202210:30 amRNSHolding(s) in Company
11th Aug 20227:00 amRNSUnaudited Results for six months ended 30.06.22
10th Aug 20224:30 pmRNSHolding(s) in Company
2nd Aug 20223:45 pmRNSHolding(s) in Company
29th Jul 20224:45 pmRNSTotal Voting Rights
26th Jul 20225:15 pmRNSHolding(s) in Company
21st Jul 20223:00 pmRNSHolding(s) in Company
18th Jul 20227:00 amRNSDisposal of Bush House WC2
30th Jun 20224:45 pmRNSTotal Voting Rights
9th Jun 202210:00 amRNSAdditional Listing
6th Jun 20222:00 pmRNSDirector/PDMR Shareholding
31st May 20224:45 pmRNSTotal Voting Rights
26th May 20223:10 pmRNSHolding(s) in Company
24th May 20225:10 pmRNSHolding(s) in Company
13th May 20221:00 pmRNSResult of AGM
10th May 20229:00 amRNSBondholders' Meeting
5th May 20227:01 amRNSCity Road Island EC1 Exchange of Contract
5th May 20227:00 amRNSQ1 2022 Business Update
29th Apr 20224:45 pmRNSTotal Voting Rights
13th Apr 20222:00 pmRNSReport and Accounts 2021 and Notice of AGM
31st Mar 20224:45 pmRNSTotal Voting Rights
22nd Mar 20229:00 amRNSBlock listing Interim Review replacement
21st Mar 20226:10 pmRNSBlock listing Interim Review
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
15th Mar 202210:45 amRNSDirector/PDMR Shareholding
10th Mar 20222:00 pmRNSDirector/PDMR Shareholding
10th Mar 202210:00 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.